Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Suoquan is a Traditional Chinese Medicine (TCM) herbal formula primarily indicated for the treatment of urinary incontinence, including stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). It is a modified version of the classic Suoquan Wan ("Shrink the Fountain Pill"), incorporating "Yiqi" (Qi-replenishing) herbs to address underlying Spleen and Kidney Qi deficiency. The formulation typically consists of *Astragalus membranaceus* (Huangqi), *Alpinia oxyphylla* (Yizhiren), *Dioscorea oppositifolia* (Shanyao), and *Lindera aggregata* (Wuyao). It is administered in several forms, most commonly as a decoction (Tang) or as granules. Clinical research has explored its efficacy both as a monotherapy and as part of a combination therapy with acupuncture or pelvic floor muscle training to improve bladder storage function and urethral closure pressure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Suoquan.